San Mateo, CA, United States of America

Timothy C Hoey


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Timothy C Hoey

Introduction

Timothy C Hoey is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on addressing hyperproliferative disorders, which are conditions characterized by excessive cell growth.

Latest Patents

Timothy C Hoey holds 1 patent for his invention titled "Anti-galanin antibodies and uses thereof." This patent provides antibodies that immunospecifically bind to a galanin peptide. The invention includes methods for preventing, treating, managing, and ameliorating hyperproliferative disorders or symptoms associated with these conditions. Additionally, it encompasses methods and compositions for diagnosing, monitoring, and prognosing hyperproliferative disorders. The patent also relates to articles of manufacture and kits that include these antibodies.

Career Highlights

Timothy is currently associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to contribute to advancements in medical science and improve patient outcomes through his research and inventions.

Collaborations

Throughout his career, Timothy has collaborated with notable colleagues, including Wade Aaron and Richard J Austin. These collaborations have further enhanced the impact of his work in the field of biotechnology.

Conclusion

Timothy C Hoey's contributions to the field of biotechnology through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to play a crucial role in developing therapies for hyperproliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…